AbstractObjectivesSurgical decision making for patients with early hepatocellular carcinoma (HCC) and well-compensated cirrhosis remains controversial. The aim of the current study was to conduct a meta-analysis of published reports to compare survival outcomes after transplantation and resection, respectively, in patients with early HCC [i.e. HCC falling within the Milan Criteria (a solitary lesion measuring ≤5cm or fewer than three lesions with a largest diameter of ≤3cm, and absence of macroscopic vascular invasion or extrahepatic disease)] and well-compensated cirrhosis.MethodsA total of 990 abstracts were identified through a PubMed-based search. Ten articles comparing transplantation and resection in patients with early HCC were inclu...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
TO EVALUATE MORBIDITY, MORTALITY, PATIENT SURVIVAL AND DISEASE-FREE SURVIVAL OF PATIENTS UNDERWENT L...
AbstractObjectivesSurgical decision making for patients with early hepatocellular carcinoma (HCC) an...
BACKGROUND: The surgical management of hepatocellular carcinoma in patients with well-compensated ci...
BACKGROUND: The surgical management of hepatocellular carcinoma in patients with well-compensated ci...
Background and aim. The choice of the best surgical strategy for early hepatocellular carcinoma (HCC...
Background and aim. The choice of the best surgical strategy for early hepatocellular carcinoma (HCC...
AbstractIntroductionLiver transplantation (LT) is a treatment option in select patients with hepatoc...
Partial hepatic resection has been the mainstay of curative treatment for hepatocellular carcinoma (...
For patients presenting with hepatocellular carcinoma within the Milan criteria, either liver resect...
Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of liver fun...
AbstractBackgroundThe present study examines the presentation and outcomes of hepatocellular carcino...
PubMedID: 31101189Background: Scarce data are available comparing outcomes of hepatic resection vs o...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
TO EVALUATE MORBIDITY, MORTALITY, PATIENT SURVIVAL AND DISEASE-FREE SURVIVAL OF PATIENTS UNDERWENT L...
AbstractObjectivesSurgical decision making for patients with early hepatocellular carcinoma (HCC) an...
BACKGROUND: The surgical management of hepatocellular carcinoma in patients with well-compensated ci...
BACKGROUND: The surgical management of hepatocellular carcinoma in patients with well-compensated ci...
Background and aim. The choice of the best surgical strategy for early hepatocellular carcinoma (HCC...
Background and aim. The choice of the best surgical strategy for early hepatocellular carcinoma (HCC...
AbstractIntroductionLiver transplantation (LT) is a treatment option in select patients with hepatoc...
Partial hepatic resection has been the mainstay of curative treatment for hepatocellular carcinoma (...
For patients presenting with hepatocellular carcinoma within the Milan criteria, either liver resect...
Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of liver fun...
AbstractBackgroundThe present study examines the presentation and outcomes of hepatocellular carcino...
PubMedID: 31101189Background: Scarce data are available comparing outcomes of hepatic resection vs o...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
There is still some debate on whether hepatic resection or liver transplantation should be the initi...
TO EVALUATE MORBIDITY, MORTALITY, PATIENT SURVIVAL AND DISEASE-FREE SURVIVAL OF PATIENTS UNDERWENT L...